Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04146961 · ClinicalTrials.gov registry record
The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
A clinical trial, sponsored by Research Insight.
- Completed
- Registry status
- 59
- Enrollment target
NCT04146961: Completed study, sponsored by Research Insight.
NCT04146961 is a clinical trial that has completed, run by Research Insight. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04146961 has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
Prospective survey study of patients who previously underwent cataract surgery with the Alcon PanOptix or PanOptix Toric intraocular lens in both eyes.
Primary Outcome
Primary objective: to determine the percentage of patients who report "top box" (5 out of 5) overall satisfaction on the questionnaire instrument. To determine the percentage of patients who report satisfaction ("satisfied" or "very satisfied" as 4 out of 5 on the attached questionnaire instrument.
Interventions
- DEVICE Alcon PanOptix or PanOptix Toric IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2019-10-05 |
| Est. Completion | 2020-07-21 |
What the finished NCT04146961 record still lists
NCT04146961 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Alcon PanOptix or PanOptix Toric IOL is the first listed.
NCT04146961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04146961 about?
NCT04146961 is a clinical study titled "The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance". Prospective survey study of patients who previously underwent cataract surgery with the Alcon PanOptix or PanOptix Toric intraocular lens in both eyes.
What is the current status of trial NCT04146961?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2019-10-05. Estimated completion is 2020-07-21.
What interventions are being tested in trial NCT04146961?
The interventions under investigation include: Alcon PanOptix or PanOptix Toric IOL (DEVICE).
Who is sponsoring clinical trial NCT04146961?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI